Charles Schwab Investment Management Inc Capricor Therapeutics, Inc. Put Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
62Shares Held
4.74MCall Options Held
123KPut Options Held
53.8K-
Vanguard Group Inc Valley Forge, PA1.37MShares$6.45 Million0.0% of portfolio
-
Black Rock Inc. New York, NY382KShares$1.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA328KShares$1.55 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA316KShares$1.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny293KShares$1.38 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $115M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...